Dr. Nithya Meenakshi Krishnan, MD

Dr. Krishnan practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Dr. Krishnan's NPI, 1396248126, was assigned on March 18, 2018. Dr. Krishnan graduated from American University of the Caribbean School of Medicine in 2018. Dr. Krishnan holds Florida license ME166905.

Dr. Krishnan's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Dr. Krishnan's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Krishnan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krishnan practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Krishnan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Krishnan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Krishnan's licenses on file in 2 states: Florida and Kansas.

CMS data shows 141 Medicare services from Dr. Krishnan across 4 procedure codes in 2024, all of them office visits, for 91 Medicare patients. Medicare paid $17,087 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Krishnan in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Krishnan's median patient age at 76, with 61% women.

In 2024, Dr. Krishnan wrote 97 Medicare Part D claims for 35 patients. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $227 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Krishnan for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 17 papers to Dr. Krishnan, published from 2012 to 2022. 2019 was the busiest year, with 4. The most frequent topics are Cell Line, Tumor, Urinary Bladder Neoplasms and Gene Expression Regulation, Neoplastic. Dr. Krishnan's most frequent co-authors are Michael K. Chahin, DO, Gurkamal Singh Chatta, MD and Hardik Satish Chhatrala, MD.

CMS Open Payments shows 3 general payments to Dr. Krishnan from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 70% of the total. Sanofi and Genzyme US Companies paid the most, $122.

Dr. Krishnan graduated from American University of the Caribbean School of Medicine in 2018.

Dr. Krishnan is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.